Alice K. Pau

4.0k total citations · 1 hit paper
60 papers, 2.7k citations indexed

About

Alice K. Pau is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Alice K. Pau has authored 60 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 28 papers in Epidemiology and 19 papers in Virology. Recurrent topics in Alice K. Pau's work include HIV/AIDS drug development and treatment (31 papers), Pneumocystis jirovecii pneumonia detection and treatment (19 papers) and HIV Research and Treatment (19 papers). Alice K. Pau is often cited by papers focused on HIV/AIDS drug development and treatment (31 papers), Pneumocystis jirovecii pneumonia detection and treatment (19 papers) and HIV Research and Treatment (19 papers). Alice K. Pau collaborates with scholars based in United States, Israel and Kenya. Alice K. Pau's co-authors include Henry Masur, King K. Holmes, Constance A. Benson, Jonathan E. Kaplan, John T. Brooks, Jomy George, Anthony S. Fauci, J. T. Brooks, John Kaplan and Mark Dybul and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Annals of Internal Medicine.

In The Last Decade

Alice K. Pau

58 papers receiving 2.6k citations

Hit Papers

Guidelines for prevention... 2009 2026 2014 2020 2009 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America
    2009 1000 citations Constance A. Benson, King K. Holmes et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alice K. Pau United States 20 1.5k 1.4k 632 317 249 60 2.7k
Juan Sierra‐Madero Mexico 27 1.0k 0.7× 1.0k 0.7× 506 0.8× 215 0.7× 308 1.2× 116 2.3k
P. Chavanet France 35 1.7k 1.2× 1.6k 1.1× 373 0.6× 271 0.9× 509 2.0× 186 3.5k
Daniel J. Skiest United States 35 2.5k 1.7× 1.6k 1.1× 1.2k 2.0× 238 0.8× 563 2.3× 100 3.9k
Daniela Francisci Italy 27 1.0k 0.7× 889 0.6× 357 0.6× 318 1.0× 328 1.3× 146 2.7k
Bruce Polsky United States 28 784 0.5× 1.4k 1.0× 436 0.7× 109 0.3× 147 0.6× 78 2.9k
Fredy Suter Italy 26 1.6k 1.1× 1.5k 1.1× 658 1.0× 234 0.7× 230 0.9× 77 2.8k
Caterina Uberti‐Foppa Italy 22 632 0.4× 1.0k 0.7× 328 0.5× 225 0.7× 146 0.6× 109 1.7k
Peter T. Frame United States 28 1.4k 0.9× 1.6k 1.1× 345 0.5× 130 0.4× 119 0.5× 44 2.6k
Katia Boggian Switzerland 21 1.4k 0.9× 1.4k 1.0× 456 0.7× 157 0.5× 358 1.4× 58 2.4k
Frank P. Kroon Netherlands 31 1.9k 1.3× 1.9k 1.3× 846 1.3× 192 0.6× 229 0.9× 87 3.8k

Countries citing papers authored by Alice K. Pau

Since Specialization
Citations

This map shows the geographic impact of Alice K. Pau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice K. Pau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice K. Pau more than expected).

Fields of papers citing papers by Alice K. Pau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice K. Pau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice K. Pau. The network helps show where Alice K. Pau may publish in the future.

Co-authorship network of co-authors of Alice K. Pau

This figure shows the co-authorship network connecting the top 25 collaborators of Alice K. Pau. A scholar is included among the top collaborators of Alice K. Pau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice K. Pau. Alice K. Pau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beavers, Craig J., Alice K. Pau, David V. Glidden, et al.. (2025). Statin Therapy as Primary Prevention for Persons With HIV: A Synopsis of Recommendations From the U.S. Department of Health and Human Services Antiretroviral Treatment Guidelines Panel. Annals of Internal Medicine. 178(6). 847–857. 4 indexed citations
2.
3.
Kuriakose, Safia, Alice K. Pau, Eric S. Daar, et al.. (2021). Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19. Annals of Internal Medicine. 174(8). 1151–1158. 13 indexed citations
4.
Soka, Moses J, Collin Van Ryn, Greg Grandits, et al.. (2021). The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West Africa. PLoS ONE. 16(9). e0257049–e0257049. 3 indexed citations
5.
Pau, Alice K., Judith A. Aberg, Pamela S. Belperio, et al.. (2020). Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel. Annals of Internal Medicine. 174(1). 93–95. 29 indexed citations
6.
Imamichi, Hiromi, Mindy Smith, Joseph W. Adelsberger, et al.. (2020). Defective HIV-1 proviruses produce viral proteins. Proceedings of the National Academy of Sciences. 117(7). 3704–3710. 149 indexed citations
7.
Boulougoura, Afroditi, Elizabeth Laidlaw, Gregg Roby, et al.. (2019). 373. Immune Reconstitution Inflammatory Syndrome in Patients with HIV/AIDS and Histoplasmosis: A Case Series. Open Forum Infectious Diseases. 6(Supplement_2). S195–S195. 2 indexed citations
8.
Grossman, Zehava, Wei Shao, Catherine Rehm, et al.. (2018). Early Presence of HIV-1 Subtype C in Washington, D.C.. AIDS Research and Human Retroviruses. 34(8). 680–684. 3 indexed citations
9.
Brooks, Kristina M., Jomy George, Alice K. Pau, et al.. (2018). Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine. Clinical Infectious Diseases. 67(2). 193–201. 45 indexed citations
10.
Penzak, Scott, et al.. (2016). Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects. Clinical Infectious Diseases. 62(8). 1036–1042. 9 indexed citations
11.
Grant, Philip, Virginia Sheikh, Rebecca DerSimonian, et al.. (2015). Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients. AIDS Research and Human Retroviruses. 31(7). 739–744. 1 indexed citations
12.
13.
Hadigan, Colleen, Cheryl Chairez, Lynnette K. Nieman, et al.. (2013). Influence of Low-Dose Ritonavir With and Without Darunavir on the Pharmacokinetics and Pharmacodynamics of Inhaled Beclomethasone. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(3). 355–361. 29 indexed citations
14.
Hu, Zonghui, Johanna Ledwaba, Lynn Morris, et al.. (2011). Genotypic Resistance at Viral Rebound Among Patients Who Received Lopinavir/Ritonavir-Based or Efavirenz-Based First Antiretroviral Therapy in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(3). 304–308. 13 indexed citations
15.
Robertson, Sarah, Scott Penzak, & Alice K. Pau. (2007). Drug interactions in the management of HIV infection: an update. Expert Opinion on Pharmacotherapy. 8(17). 2947–2963. 22 indexed citations
16.
Pau, Alice K., et al.. (2006). Predictors for Hematopoietic Growth Factors Use in HIV/HCV-Coinfected Patients Treated with Peginterferon Alfa 2b and Ribavirin. AIDS Patient Care and STDs. 20(9). 612–619. 6 indexed citations
17.
Robertson, Sarah, Scott Penzak, Jason Lane, Alice K. Pau, & JoAnn M. Mican. (2005). A Potentially Significant Interaction between Efavirenz and Phenytoin: A Case Report and Review of the Literature. Clinical Infectious Diseases. 41(2). e15–e18. 19 indexed citations
18.
Robertson, Sarah, Scott Penzak, & Alice K. Pau. (2005). Drug interactions in the management of HIV infection. Expert Opinion on Pharmacotherapy. 6(2). 233–253. 15 indexed citations
19.
Pau, Alice K.. (2002). Therapeutic use of interleukin-2 in HIV-infected patients. Current Opinion in Pharmacology. 2(4). 433–439. 10 indexed citations
20.
Piscitelli, Stephen C., et al.. (2000). The Effect of Ritonavir on the Pharmacokinetics of Meperidine and Normeperidine. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(5). 549–553. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan Sierra‐Madero Breakdown of academic impact, for papers by P. Chavanet Breakdown of academic impact, for papers by Daniel J. Skiest Breakdown of academic impact, for papers by Daniela Francisci Breakdown of academic impact, for papers by Bruce Polsky Breakdown of academic impact, for papers by Fredy Suter Breakdown of academic impact, for papers by Caterina Uberti‐Foppa Breakdown of academic impact, for papers by Peter T. Frame Breakdown of academic impact, for papers by Katia Boggian Breakdown of academic impact, for papers by Frank P. Kroon
Rankless by CCL
2026